AUTOLOGOUS BONE MARROW DERIVED MONONUCLEAR CELL THERAPY FOR COMPARTMENT SYNDROME YEAR 3 AND 4.

$2,444,439FY2011Department of DefenseDOD

Arteriocyte, Inc., Cleveland OH

Investigators